| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/09/2008 | CN100400051C Medicinal composition, and its preparing method and use |
| 07/09/2008 | CN100400050C Stable pharmaceutical composition useful for treating gastrointestinal disorders |
| 07/09/2008 | CN100400049C Medicinal powder for treating beriberi |
| 07/09/2008 | CN100400048C Application of physalis alkekengi polysaccharide in preparation of medicine and health care product for treating diabetes |
| 07/09/2008 | CN100400047C Medicine powder for injection for treating cardiac and cerebral vascular diseases and its preparing method and application |
| 07/09/2008 | CN100400046C Remedies for lung cancer |
| 07/09/2008 | CN100400045C Nucleic acid-based compounds and methods of use thereof |
| 07/09/2008 | CN100400043C Utilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances |
| 07/09/2008 | CN100400042C Methods for making sustained release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 07/09/2008 | CN100400041C Diaminothiazoles used as CDK4 inhibitors |
| 07/09/2008 | CN100400040C Tripeptidyl peptidase inhibitors |
| 07/09/2008 | CN100400039C Composition for treating tumours and its use |
| 07/09/2008 | CN100400038C Compound soft lutein capsule and its preparing process |
| 07/09/2008 | CN100400037C Medicine composition containing borneol and musk |
| 07/09/2008 | CN100400035C Clopidogrel sulfate solid preparation, and its preparing method |
| 07/09/2008 | CN100400031C Powdery preparations and proecss for producing the same |
| 07/09/2008 | CN100399941C Process for producing one or more kinds of dry powder of carotenoid |
| 07/09/2008 | CN100399917C Method for preparing milk tablets contg micron ginseng and antler etc., with tonifying-kidney and eliminating-fatigue functions |
| 07/09/2008 | CN100399897C Formulations comprising triazoles and alkoxylated amines |
| 07/09/2008 | CA2573484A1 Plant compositions enriched in dehydrosoyasaponin i (d-i) and methods of producing such compositions |
| 07/08/2008 | WO2008083353A1 Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/08/2008 | US7396954 Alkyl 2-[4-(1-hydroxy-2,2-dialkoxyethyl)-2,5-dimethylphenoxy]acetate, which is an intermediate for preparing alkyl 2-[4-[2-[2-hydroxy-2-(4-hydroxyphenyl)-1-methyethyl]amino]ethyl]-2,5-dimethylphenoxy]acetate |
| 07/08/2008 | US7396953 Angiogenesis inhibitors and pharmaceutical/cosmetic applications thereof |
| 07/08/2008 | US7396946 Compound for treatment of external secretion disorders |
| 07/08/2008 | US7396944 Thiophene derivatives, their manufacture and use as pharmaceutical agents |
| 07/08/2008 | US7396940 Randomized library of 500-10000 different compounds immobilized on a solid support; biosynthessis by the Suzuki reaction using a platinum catalyst and boronic acid derivative; antagonists against chemoattractant receptors such as chemokine receptors, particularlyCCR6; antiinflammatory agents |
| 07/08/2008 | US7396938 Process for making multifunctional tetrazole polyols to produce tetrazole based polymers |
| 07/08/2008 | US7396936 Modulators of calcitonin and amylin receptor activity |
| 07/08/2008 | US7396935 p38 kinase inhibitors; inflammatory bowel disease, rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease, and congestive heart failure |
| 07/08/2008 | US7396927 Process for preparation of rosuvastatin calcium |
| 07/08/2008 | US7396910 Transient receptor potential channel TRPV3 and its use |
| 07/08/2008 | US7396860 Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis |
| 07/08/2008 | US7396859 Perturbed membrane-binding compounds |
| 07/08/2008 | US7396858 Biguanide derivative and therapeutic agent for diabetes containing the same |
| 07/08/2008 | US7396857 side effects reduction; 5-HT2C receptor agonists or partial agonists; 1-{7-[3,5-bis(trifluoromethyl)phenyl]-2,3-dihydro-1-benzofuran-2-yl}methanamine; mood disorders |
| 07/08/2008 | US7396856 Benzopyran analogs and their use for the treatment of glaucoma |
| 07/08/2008 | US7396855 Foods; skin, lipid, liver, and cardiovascular disorders; hormone dependent diseases, osteopenia, osteoporosis,and acute ovarian estrogen deficiency; biosynthesis by metabolism of isoflavone; drug delivery |
| 07/08/2008 | US7396854 Use of serotonergic compound for a method of treatment of hot flushes in post-menopausal women |
| 07/08/2008 | US7396853 2-phenyl-3,3,3-trifluoro-2-hydroxy-propionic acid derivatives |
| 07/08/2008 | US7396852 Compounds or polymers with divalent linkage of thiophene, phenyl, vinylene, ethynylene for example; organic semiconductors for use in organic thin film transistors (OTFTs); e.g. aromatic resin based on 2,8-bis(2-thienyl)-5,11-didodecylindolo[3,2-b]carbazole |
| 07/08/2008 | US7396851 Heterocyclic and benzoheterocyclic polyamides structurally related to the natural antibiotic distamycin A for the treatment of β-thalassaemia |
| 07/08/2008 | US7396850 Pyrazole derivative as PPAR modulator |
| 07/08/2008 | US7396849 Chronic pain, allodynia, muscle spasticity, diarrhea, neuropathic pain; compounds have no or only minimal cardiovascular and/or sedatory activity; minimal side effects; 4-Benzo[1,2,5]thiadiazol-4-ylmethyl-1,3-dihydro-imidazole-2-thione |
| 07/08/2008 | US7396848 oxazole derivatives to treat diabetic neuropathy and/or other kinds of peripheral neuropathy; 4-(4-chlorophenyl)-5-[3-(2-methoxyphenoxy)propyl]-2-(2-methyl-1-imidazolyl)oxazole |
| 07/08/2008 | US7396847 Oxazolidinone and/or isoxazoline as antibacterial agents |
| 07/08/2008 | US7396846 Growth hormone secretagogues |
| 07/08/2008 | US7396844 3-(4-amidinobenzoylamino)-4-[5-amidino-2-(2-carboxy-2-oxoethyl)phenoxy]butanoic acid; anticoagulant; blood coagulation factor X and thrombin inhibitor; cerebral infarction, thrombosis, embolism, transient ischemic attack (TIA) and subarachnoidal hemorrhage (vasospasm); ischemic heart diseases |
| 07/08/2008 | US7396843 5′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/08/2008 | US7396842 Five-membered cyclic compounds |
| 07/08/2008 | US7396841 Injections |
| 07/08/2008 | US7396840 Chemokine receptor binding heterocyclic compounds |
| 07/08/2008 | US7396838 antitumor, anticarcinogenic agents; cytotoxic activity and angiogensis inhibitors; leukemia, colorectal cancer; orally |
| 07/08/2008 | US7396837 topoisomerase I inhibitors; stimulate topoisomerase I-mediated DNA cleavage and their cytotoxic potential; antitumor agent; prostate gland, ovaries, colon cancer; marine alkaloids |
| 07/08/2008 | US7396836 Pyrimidine compound and medicinal composition thereof |
| 07/08/2008 | US7396835 Simplified process for preparation of 6-[(substituted)phenyl]-triazolopyrimidine compounds which may be useful in the treatment of cancer |
| 07/08/2008 | US7396834 e.g., 3-[(4-[(diethylamino)carbonyl]phenyl)(4-benzyl-piperazin-1-yl)methyl]benzamide; opioid delta rreceptor agonist; analgesic, hypotensive agent; pain, anxiety and functional gastrointestinal disorders, immunomodulatory activities |
| 07/08/2008 | US7396833 Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof |
| 07/08/2008 | US7396832 Inhibitors of Akt activity |
| 07/08/2008 | US7396831 Vanilloid receptor ligands and their use in treatments |
| 07/08/2008 | US7396830 Piperazine amidines as antiviral agents |
| 07/08/2008 | US7396829 such as 2H-1,2,4-benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-3-[5-(nitrooxy)pentyl]-, 1,1-dioxide; contains at least one nitric oxide enhancing group; excessive water or electrolyte retention conditions; cardiovascular diseases, and diseases resulting from oxidative or endothelial dysfunctions |
| 07/08/2008 | US7396828 PI-3 kinase inhibitor prodrugs |
| 07/08/2008 | US7396827 Pharmaceutical compositions and treatment methods |
| 07/08/2008 | US7396826 prophylaxis/therapy of diabetes, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative and neuropathic diseases, neuropathic pain, polyneuropathy using e.g. Octadeca-6,9,12-trienoic acid 5' -(2,4-dioxo-3,4-dihydro-2H-pyrimidine-1-yl)-3',4 dihydroxy-tetrahydrofuran-2'-yl methyl ester |
| 07/08/2008 | US7396825 Agonists of A2A adenosine receptors for treatment of diabetic nephropathy |
| 07/08/2008 | US7396824 2-O sulfatase nucleic acid compositions |
| 07/08/2008 | US7396823 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis |
| 07/08/2008 | US7396821 Applying non-invasive external pressure against the skin of a limb of a mammal to impede blood flow; inserting a polynucleotide encoding a protein linked to a promoter into a blood vessel in vivo distal to the applied pressure; and administering immunosuppressive drugs |
| 07/08/2008 | US7396820 Anthelmintic formulations |
| 07/08/2008 | US7396819 contain ivermectin plus hexahydropyrazinoisoquinolines (praziquantel ) and tetrahydropyrimidines (pyrantel); treating tapeworm, hookworm, roundworm and heartworm of domestic animals |
| 07/08/2008 | US7396818 Sulfotransferase inhibitor |
| 07/08/2008 | US7396811 Subcellular targeting of therapeutic proteins |
| 07/08/2008 | US7396663 Isolated polynucleotide encoding a G-protein coupled receptor |
| 07/08/2008 | US7396661 Expressing Fab/immunoglobulin fragments in bacterial cells; diagnosis and treatment of diabetes, multiple sclerosis and rheumatoid arthritis |
| 07/08/2008 | US7396660 Expression vector comprising nucleotide sequences coding polyketide synthase for use in transformation, and propagation of streptomyces cells capable of producing moxidectin; bactericides; nematocide |
| 07/08/2008 | US7396659 Suppresses activity of HMG-CoA reductase; cytokine induction suppressor; lovastatin, mevastatin |
| 07/08/2008 | US7396547 Antiseptic composition |
| 07/08/2008 | US7396546 Anti-microbial compositions and methods of using same |
| 07/08/2008 | US7396545 Preparation for cardio-cerebral blood vessel diseases and its preparing method |
| 07/08/2008 | US7396542 Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof |
| 07/08/2008 | US7396538 Biocompatible polymer drug release matrix comprising a thermoplastic polyurethane elastomer and drug (quinone-containing alkylating agents of a mitomycin family) incorporated into the biocompatible polymer matrix; inhibit proliferation of smooth muscle cells causing restenosis |
| 07/08/2008 | US7396527 Antibiotic polymers |
| 07/08/2008 | US7396526 Skin care composition |
| 07/08/2008 | US7396525 Care/makeup compositions comprising a 2-alkylideneaminooxyacetamide compound for stimulating the growth of the hair or eyelashes and/or slowing loss thereof |
| 07/08/2008 | CA2710043A1 Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/08/2008 | CA2675451A1 Combination therapy with angiogenesis inhibitors |
| 07/08/2008 | CA2533061C Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 07/08/2008 | CA2501321C Pharmaceutical composition comprising crystalline sibutramine methanesulfonate hemihydrate |
| 07/08/2008 | CA2497349C Perivascular wraps |
| 07/08/2008 | CA2488397C Crystal form ii of clarithromycin |
| 07/08/2008 | CA2487436C Production process for lactulose-containing powder composition, lactulose-containing powder composition produced by same, and feed additive |
| 07/08/2008 | CA2481220C Dietary methods for canine performance enhancement |
| 07/08/2008 | CA2445620C Tetracyclic compounds as pde5-inhibitors |
| 07/08/2008 | CA2438596C Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders |
| 07/08/2008 | CA2436536C Methods for inducing apoptosis and inhibiting proliferation in cancer cells |
| 07/08/2008 | CA2432131C Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2008 | CA2424000C Use of methylene blue and related compounds to prevent or reverse an exaggerated hemodynamic reaction |
| 07/08/2008 | CA2422819C Food supplement |
| 07/08/2008 | CA2420177C Quinazoline derivatives as alpha-1 adrenergic antagonists |
| 07/08/2008 | CA2402635C Method for oxidizing a thioether group into a sulfoxide group |